doi: 10.1016/S0140-6736(19)31150-X 6 SterneJACSavovicJPageMJElbersRGBlencoweNSBoutronIet al
When the medication activates those receptors, the result isn't only reduced hunger it may also blunt the thirst sensation that would normally prompt you to drink
Ongoing research on GLP-1s may demonstrate previously unknown off-target effects
The attached fatty acid moiety fosters binding to serum albumin, which delays renal excretion
IBD is a chronic relapsing-remitting inflammatory condition encompassing ulcerative colitis (UC) and Crohns disease (CD), affecting approximately 6.8 million patients globally in 2017
Because the dual-agonist mechanism engages both the GIP and GLP-1 pathways, the research is often discussed alongside single-agonist data, but the two compounds are not interchangeable, and any comparison belongs in a conversation with a qualified provider who knows your history